Hims & Hers gains on partnership with Eli Lilly

Seeking Alpha · Dulan Lokuwithana · 2026-11-06 12:35 UTC

Hims & Hers Health (HIMS) stock rises as the company inks a partnership to sell Eli Lilly's (LLY) weight-loss drugs, Zepbound and Foundayo. Read more here.

Nov 06, 2026, 7:35 AM ETHims & Hers Health, Inc. (HIMS) Stock, LLY StockNVOBy: Dulan Lokuwithana, SA News Editor

Shares of Hims & Hers Health (HIMS) rose in premarket trading on Friday after the telehealth platform and Eli Lilly (LLY) announced a partnership to deliver the Indiana-based drugmaker’s weight loss drugs, Zepbound and Foundayo, directly to cash-paying patients.

Lilly (

Read the full story at Seeking Alpha · All coverage of this story